Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

NCT00006011 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

659

Enrollment

NETWORK

Sponsor class

Conditions

Endometrial Adenocarcinoma
Endometrial Adenosquamous Carcinoma
Endometrial Clear Cell Adenocarcinoma
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
Endometrial Serous Adenocarcinoma
Stage III Uterine Corpus Cancer

Interventions

DRUG: Doxorubicin Hydrochloride
DRUG: Cisplatin
BIOLOGICAL: Filgrastim
BIOLOGICAL: Pegfilgrastim
DRUG: Paclitaxel

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]
[object Object]